Physician profile
Christi Wallace
NPI 1346535358
$5,424.91
in general payments reported to CMS, 2019-2025
39 companies · $766 in 2025
The $766 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $438 · 2021: $782 · 2022: $566 · 2023: $924 · 2024: $1,650 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,340.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $898.51 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Corium, LLC | $647.23 | 2023-2025 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $524.36 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $353.21 | 2019-2024 | Prolia, Evenity |
| Corcept Therapeutics | $353.10 | 2024-2025 | Korlym |
| Novo Nordisk INC | $287.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $274.58 | 2020-2025 | Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $267.14 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $259.16 | 2019-2025 | |
| Adlon Therapeutics L.P. | $193.73 | 2020-2021 | |
| Exact Sciences Corporation | $191.67 | 2023-2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $143.61 | 2020-2023 | |
| Axsome Therapeutics, INC. | $91.96 | 2023 | Auvelity |
| Sumitomo Pharma America, INC. | $90.36 | 2023-2024 | Gemtesa |
| Tris Pharma INC | $85.51 | 2023-2024 | Dyanavel Xr |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christi Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.